Medicamen Organics Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Medicamen Organics Limited's yearly results (2023–2026), compared with companies in India. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹-483 of operating cash. Lower than almost all companies in India.
- Cash Locked Ratio: For every ₹100 of sales, ₹104 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹34 tied up three years earlier. More money tied up than 95% of companies in India.
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 92% of companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹-483Over the last 3 years, every ₹100 of reported profit came with ₹-483 of operating cash.
Lower than almost all companies in India.
Self-Funding Ratio
-2.8×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 92% of companies in India.
Cash Locked Ratio
₹104For every ₹100 of sales, ₹104 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹34 tied up three years earlier.
More money tied up than 95% of companies in India.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Less steady than 58% of companies in India.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by +2% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
+2% / +58%In 3 years sales changed by +2% while total assets changed by +58%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-0.3×Operating cash was negative last year, while some debt falls due within a year.
Lower than 88% of companies in India.
Cash Cushion Ratio
−44%Debt, after subtracting cash, equals 44% of its market value (net debt).
Lower than 83% of companies in India.
Tangible Assets Ratio
99%Of every ₹100 the company owns, ₹99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 61% of companies in India.
Tangible Net Worth Ratio
98%Of every ₹100 of net worth, ₹98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 60% of companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Medicamen Organics Limited made a loss over the last year. Medicamen Organics Limited owes ₹0.45 for every ₹1 it owns. Medicamen Organics Limited made a loss in the year to Mar 2026, after a profit the year before.
Compared with companies in India · latest annual results Mar 2026.
P/E ratio
LossMedicamen Organics Limited made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.04The share price is 1.04 times Medicamen Organics Limited's book value per share, lower than 78% of companies in India.
Market cap
₹30 CrThe total market value of all of Medicamen Organics Limited's shares at today's price (share price × number of shares), smaller than 96% of companies in India. PosiCap size class: Nano Cap.
Net worth (book value)
₹29 CrWhat Medicamen Organics Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹24.55Net worth divided by the number of shares. The share price of ₹25.45 is 1.0 times this, which is the P/B above.
Owes vs Owns
0.45×Medicamen Organics Limited owes ₹0.45 for every ₹1 it owns (low), higher than 54% of companies in India.
Revenue growth
-41%Revenue fell 41% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Profit growth
LossMedicamen Organics Limited made a loss in the year to Mar 2026, after a profit the year before.
Profit margin
-17.8%Medicamen Organics Limited lost ₹18 for every ₹100 of revenue.
Interest cover
Not coveredMedicamen Organics Limited's operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net debtMedicamen Organics Limited had ₹13 Cr more debt than cash (net debt) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Medicamen Organics Limited: ₹30 Cr ÷ ₹29 Cr (31 Mar 2026) = 1.0.
How much does Medicamen Organics Limited owe compared with what it owns?
Medicamen Organics Limited owes ₹0.45 for every ₹1 it owns (low), higher than 54% of companies in India.
Is Medicamen Organics Limited's revenue growing?
Revenue fell 41% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.